Alto Neuroscience, Inc. ANRO
22.70 USD +0.51 (+2.30%)
At closeNov 3, 2026, 4:01 PM EST
22.70 0.00 0.00%
After hours · Nov 3, 4:01 PM ET
22.40 Day range 23.14
11.13 52-week range 36.64
- YTD
- +27.53%
- 1 year
- +86.52%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 38.38 +69.1% upside
Now 22.70
- Target (low)
- 26.00
- Target (mean)
- 38.38
- Target (high)
- 55.00
Ratings (0m) 11 10 buy · 1 hold · 0 sell
- Strong buy0
- Buy10
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 11
- 1 month ago 11
- 2 months ago 11
- 3 months ago 12
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.70286 | -0.89 – -0.60 | -0.52 | -35.2% | 0 | 0.0% | 7 |
| Next quarter | -0.72571 | -0.92 – -0.61 | -0.45 | -61.3% | 0 | 0.0% | 7 |
| Current year | -2.92 | -3.33 – -2.61 | 0.00 | 0.0% | 0 | 0.0% | 6 |
| Next year | -3.29 | -4.10 – -2.23 | -2.92 | -12.5% | 0 | 0.0% | 7 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 17, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 13, 2026 | Wedbush | Maintained | Neutral | Neutral |
| Aug 13, 2026 | BTIG | Maintained | Buy | Buy |
| May 18, 2026 | Baird | Maintained | Outperform | Outperform |
| May 14, 2026 | Wedbush | Maintained | Neutral | Neutral |
| May 11, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 22, 2026 | Chardan Capital | Maintained | Buy | Buy |
| Apr 2, 2026 | Baird | Maintained | Outperform | Outperform |
| Apr 2, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 2, 2026 | Jones Trading | Maintained | Buy | Buy |
| Apr 2, 2026 | Wedbush | Maintained | Neutral | Neutral |
| Apr 2, 2026 | Chardan Capital | Maintained | Buy | Buy |
| Mar 18, 2026 | Baird | Maintained | Outperform | Outperform |
| Mar 17, 2026 | Chardan Capital | Maintained | Buy | Buy |
| Mar 17, 2026 | Wedbush | Maintained | Neutral | Neutral |
| Feb 17, 2026 | BTIG | Maintained | Buy | Buy |
| Jan 5, 2026 | Chardan Capital | Maintained | Buy | Buy |
| Nov 17, 2025 | BTIG | Initiated | — | Buy |
| Nov 13, 2025 | Baird | Maintained | Outperform | Outperform |
| Nov 12, 2025 | Jefferies | Maintained | Buy | Buy |
| Oct 24, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Oct 20, 2025 | Baird | Maintained | Outperform | Outperform |
| Sep 29, 2025 | Chardan Capital | Initiated | — | Buy |
| Aug 18, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 26, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 15, 2025 | Wedbush | Reiterated | Neutral | Neutral |
| Apr 7, 2025 | HC Wainwright & Co. | Initiated | — | Buy |
| Dec 16, 2024 | Jones Trading | Initiated | — | Buy |
| Nov 13, 2024 | Stifel | Maintained | Buy | Buy |
| Oct 23, 2024 | Wedbush | Downgrade | Outperform | Neutral |